Crush Injury Medications in Personal Injury Cases: Rhabdomyolysis and Compartment Syndrome

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 7 min read

Crush injuries from vehicle entrapment, industrial accidents, and building collapses carry life-threatening risks including rhabdomyolysis and compartment syndrome. Learn which medications manage these injuries and how a pharmacy lien covers the treatment protocol.

A crush injury is tissue damage caused by prolonged compression of a body part — typically a limb — by heavy objects, vehicle components, or structural debris. In personal injury cases, crush injuries occur during vehicle entrapment following collisions, industrial machinery accidents, construction site collapses, and pedestrian knockdowns where a vehicle tire or frame pins the victim. Crush injuries carry unique medical risks including rhabdomyolysis (muscle breakdown releasing toxic proteins into the bloodstream), compartment syndrome (dangerous pressure buildup within muscle compartments), and acute kidney injury.

• Crush injuries require urgent, aggressive medication management to prevent potentially fatal complications including kidney failure and cardiac arrest from electrolyte disturbances
• Treatment spans weeks to months, covering acute resuscitation support, pain management, renal protection, wound care, and rehabilitation
• The LienScripts pharmacy lien program covers all crush injury prescriptions at zero upfront cost, with the lien resolved from settlement proceeds
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages
• As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Crush injury medication records document one of the most complex and dangerous injury patterns in personal injury — the pharmacologic profile alone demonstrates the severity of these cases"

Rhabdomyolysis: The Primary Pharmacologic Concern

When muscle tissue is compressed for an extended period, the damaged cells release myoglobin, potassium, phosphorus, and creatine kinase into the bloodstream upon decompression. This syndrome — rhabdomyolysis — can cause acute kidney injury as myoglobin precipitates in the renal tubules, hyperkalemia that can trigger fatal cardiac arrhythmias, and metabolic acidosis.

IV fluid resuscitation is the cornerstone of rhabdomyolysis treatment. While administered in hospital, the prescriptions for oral fluid management and electrolyte replacement continue after discharge.

Sodium bicarbonate — oral or IV — alkalinizes the urine, which helps prevent myoglobin precipitation in the kidney tubules. This may be prescribed as oral bicarbonate tablets for continued use after hospital discharge.

Calcium supplementation may be needed if hypocalcemia develops from calcium-phosphorus binding during rhabdomyolysis.

Potassium management — medications to lower serum potassium (sodium polystyrene sulfonate or patiromer) if hyperkalemia persists.

Loop diuretics (furosemide) — used cautiously to maintain urine output and facilitate myoglobin clearance, prescribed after hospital discharge if renal recovery is ongoing.

Pain Management

Crush injury pain is severe and multidimensional, involving deep tissue damage, nerve injury, and ischemic pain from compromised blood flow.

Opioid analgesics are required for weeks after a crush injury. Oxycodone, hydrocodone/acetaminophen, or morphine (transitioning from IV to oral upon hospital discharge) provide necessary pain control. The pain intensity is high enough that non-opioid alternatives alone are insufficient in the acute and early recovery phases.

Acetaminophen is used as a scheduled adjunct to reduce total opioid requirements. NSAIDs are used cautiously or avoided entirely in patients with renal involvement from rhabdomyolysis.

Gabapentin or pregabalin is introduced early because crush injuries commonly damage peripheral nerves, producing neuropathic pain — burning, tingling, shooting, or electric sensations — in the affected limb. Nerve damage may be from direct compression, ischemia, or surgical decompression.

Muscle relaxants — cyclobenzaprine, tizanidine, or baclofen — manage the spasm and contracture that develop in damaged and recovering muscle tissue.

Ketamine (low-dose oral) may be prescribed for refractory crush injury pain, particularly when opioid tolerance develops or when neuropathic components are prominent.

Compartment Syndrome Management

Compartment syndrome occurs when swelling within a fascial compartment raises pressure to the point where blood flow is compromised, causing ischemia to muscles and nerves. Emergency fasciotomy (surgical opening of the compartment) is the definitive treatment, but the post-surgical medication protocol is extensive:

• Wound care medications — post-fasciotomy wounds are often left open initially and require topical antimicrobials, wound irrigation solutions, and dressing supplies
• Antibiotics — systemic antibiotics (cephalosporins, fluoroquinolones, or broader coverage depending on wound contamination) for open wound management
• DVT prophylaxis — enoxaparin or oral anticoagulants — because crush injury patients are at high risk for deep vein thrombosis from vascular damage and immobility

Rehabilitation Phase Medications (Weeks 4-16+)

As acute management resolves and rehabilitation begins:

Opioid taper — gradual reduction with transition to tramadol or non-opioid alternatives. The taper timeline depends on injury severity and surgical interventions.

NSAIDs may be introduced once renal function normalizes, for management of rehabilitation-related inflammation and pain.

Continued gabapentin or pregabalin for neuropathic pain, which often persists for months or permanently after crush injuries.

Iron supplementation — if the patient developed anemia from myoglobin-related renal stress or surgical blood loss.

Topical wound care agents continue for fasciotomy sites and skin grafts if required.

Documentation Value for Settlement

Crush injury cases are among the highest-value personal injury claims because the injuries are severe, the complications are life-threatening, and the recovery is prolonged. The medication record powerfully documents this:

• Acute severity — rhabdomyolysis management medications, renal protection agents, and intensive pain control demonstrate a medical emergency
• Complication breadth — prescriptions spanning pain, nerve damage, wound care, DVT prevention, and renal support show multi-system involvement
• Treatment duration — months of continuous prescription fills document prolonged recovery
• Permanent consequences — ongoing neuropathic medication refills demonstrate lasting damage

The LienScripts platform captures every prescription in a structured format for the demand package.

Related Resources

• Complex Regional Pain Syndrome Medications in PI
• Pelvic Injury Medications in Personal Injury Cases
• Gabapentin for Nerve Pain After a Car Accident
• Burn and Wound Medications in Personal Injury Cases